Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phthisis Diagnostics Welcomes New Sales Director and Controller

Published: Monday, May 14, 2012
Last Updated: Monday, May 14, 2012
Bookmark and Share
Appointment of Betty Polk and Robert Owen to Company’s management team.

Phthisis Diagnostics of Charlottesville, VA has recruited two new members to its management team. Betty Polk joins the company as Business Development and Global Sales Director and Robert Owen as Controller.

According to company President and Chief Science Officer Crystal Icenhour, PhD, “Phthisis is excited to welcome Betty and Robert to its team! Betty brings a wealth of clinical laboratory and diagnostic sales experience. And Robert’s business and financial background strengthens our corporate structure.”

Betty Polk, M (ASCP), RM (NRCM) brings more than 40 years of experience in microbiology and biotechnology to her new position.

Well respected in the industry, she has supervised hospital labs, owned her own independent reference lab, and managed national sales for several companies.

Her niche has become combining science with sales, a challenge she enjoys (“The joy is in the hunt”), especially when the company is young and developing and she has the opportunity to be creative.

She has now worked with four start-up companies, including one where she played a key role in developing sales revenues from zero to a million dollars per week over a seven-year period.

Ms. Polk’s experience has included positions with Gibco Diagnostics; Sigma Chemical Co., Cell Culture Division; TechLab, Inc.; Gen-Probe/Prodesse, Inc.; and bioMerieux.

She holds a B.A. in Microbiology from the University of South Florida, is a Registered Microbiologist with the American Society for Microbiology’s National Registry of Certified Microbiologists, and is a Technologist in Microbiology with the American Society for Clinical Pathology.

As the company’s new Controller, Robert Owen, CPA, looks forward to leveraging his expertise to impact its development: “I love to feel that strong, direct connection between my work and the company’s growth.”

Mr. Owen, who has broad experience in public accounting, also has developed special expertise in biotechnology grant accounting. He sees his abilities in budgeting and grant accounting as key skills that will play an important role in the company’s further development.

As a Controller, Mr. Owen followed the development of a new anti-depressant drug (Viibryd®) through various company ownerships to the drug’s FDA approval in 2011. Another drug being developed as a vasodilator for use in cardiac stress testing (Stedivaze) was in Phase III clinical trials.

He has also been Controller at PGxHealth, LLC, a division of Clinical Data, Inc. (NASDAQ-CLDA) and at Adenosine Therapeutics, LLC until it was acquired by PGxHealth; Trovis Pharmaceuticals; and Dogwood Pharmaceuticals.

He is a Certified Public Accountant and member of the American Institute of Certified Public Accountants. He holds a B.S. degree from Concord University in Business Administration with a concentration in Accounting.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Genetic Tug of War Before Cells Decide Fate
Researchers report that as developing blood cells are triggered by genetic signals firing on and off, a 'tug of war' occurs.
Linkage Biosciences Awarded NHS Contract
Comapny announces that it has been awarded a four-year contract by NHS Blood and Transplant (NHSBT) in the UK for implementation of the LinkSeq™ Real-Time PCR HLA typing product.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Frankfurter Fraud: Finding Out What’s In Your Hot Dog
Scientists have developed a technique to test the meat content of Frankfurters.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Keeping Cells in Shape to Fight Sepsis
Boosting levels of a protein that controls the shape and activity of a crucial group of white blood cells improves survival and recovery chances during sepsis.
This 3D Printer Can Detect Infectious Diseases
Researchers at AI Biosciences, Inc. have repurposed 3D printers into machines capable of performing sample preparation and DNA amplification.
Natera, UCSF Announce Collaboration
Joint research program to study DNA markers of kidney transplant rejection.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!